Company
Medshape
Last checked: Nov 19, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
11
510(k), De Novo and PMA
Device trials
6
As lead sponsor, any status
Adverse event reports
19
Received Nov 1, 2025 to Nov 19, 2026
Recall records
3
One per recalled product
This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.
Financing
Not publicly listed. It has raised money in private placements reported to the SEC on Form D (filings through 2026Q3). A company with no recent filing may since have been acquired.
Total raised (reported)
$6.8M
2 Form D offerings, 2012 to 2014
Equity
$6.8M
Stock sold for cash
Debt and convertible notes
$0
Loans and notes sold to investors
Last known valuation
Unknown
Form D filings do not report valuation
Latest round: equity, $700K raised of $4.0M sought, first sale Jul 28, 2014, 2 investors.
Funding rounds (Form D)
One row per Form D offering, newest first. The amount raised is the latest amended figure. An offering can run for months and close in several tranches. Matched by company name, so check the filing.
| First sale | Type | Raised | Round size | Investors | Exemption and agent | Filing |
|---|---|---|---|---|---|---|
| Jul 28, 2014 | Equity | $700K | $4.0M | 2 | Rule 506(b) | Form D/A ↗Aug 22, 20141 amendment |
| Jun 18, 2012 | Equity | $6.1M | $8.0M | 9 | Rule 506 | Form D/A ↗Feb 27, 20132 amendments |
Company details
From the company's latest Form D.
- Legal name
- MedShape, Inc.
- Headquarters
- Atlanta, Georgia
- Incorporated
- Georgia over five years before filing
- Entity type
- Corporation
- Revenue range
- $1,000,001 - $5,000,000
- Industry filed under
- Biotechnology
- SEC filer
- CIK 1463845 ↗
Executives, directors and promoters
As listed on the latest Form D.
2 more people on the filing with a free account
Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.
Investors
5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.
Latest FDA decisions
The 8 newest of 11 since 2015.
K260995 · Decided Sep 23, 2026 · 181 days after receipt
Device type: Screw, Fixation, Bone (HWC) · Orthopedic Surgery
K254110 · Decided Mar 18, 2026 · 89 days after receipt
Device type: Screw, Fixation, Bone (HWC) · Orthopedic Surgery
K250628 · Decided Sep 12, 2025 · 193 days after receipt
Device type: Rod, Fixation, Intramedullary And Accessories (HSB) · Orthopedic Surgery
8 more FDA decisions with a free account
Device trials
Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.
NCT04784156 · 60 participants (planned) · Start Jun 2021 · Primary completion Mar 2024
Device: DynaNail Mini · For: Foot Arthritis
Sites: Charleston, South Carolina
- The Use of a Dynamic Sustained Compression Intramedullary Nail for Tibiotalocalcaneal ArthrodesisStatus unknown
NCT04831645 · 45 participants (planned) · Start May 24, 2021 · Primary completion May 24, 2024
Device: DynaNail · For: Ankle Arthritis; Arthritis Foot
Sites: Worthington, Ohio
NCT03747952 · 30 participants (planned) · Start May 14, 2019 · Primary completion May 2024
Device: DynaNail · For: Ankle Arthritis; Foot Arthritis
Sites: Galveston, Texas
3 more trials with a free account
Reports received
19
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
7
37% of reports
Injury reports
12
63% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 0 | 0 | 0 | 0 |
| Jan 24 | 0 | 0 | 0 | 0 |
| Feb 24 | 0 | 3 | 0 | 0 |
| Mar 24 | 0 | 1 | 0 | 0 |
| Apr 24 | 0 | 0 | 0 | 0 |
| May 24 | 0 | 1 | 0 | 0 |
| Jun 24 | 0 | 0 | 0 | 0 |
| Jul 24 | 1 | 1 | 0 | 0 |
| Aug 24 | 1 | 3 | 0 | 0 |
| Sep 24 | 0 | 2 | 0 | 0 |
| Oct 24 | 0 | 3 | 0 | 0 |
| Nov 24 | 1 | 0 | 0 | 0 |
| Dec 24 | 0 | 0 | 0 | 0 |
| Jan 25 | 3 | 1 | 0 | 0 |
| Feb 25 | 0 | 0 | 0 | 0 |
| Mar 25 | 0 | 2 | 0 | 0 |
| Apr 25 | 3 | 2 | 0 | 0 |
| May 25 | 0 | 1 | 0 | 0 |
| Jun 25 | 0 | 3 | 0 | 0 |
| Jul 25 | 0 | 0 | 0 | 0 |
| Aug 25 | 0 | 2 | 0 | 0 |
| Sep 25 | 1 | 1 | 0 | 0 |
| Oct 25 | 0 | 0 | 0 | 0 |
| Nov 25 | 0 | 2 | 0 | 0 |
| Dec 25 | 5 | 3 | 0 | 0 |
| Jan 26 | 0 | 0 | 0 | 0 |
| Feb 26 | 0 | 1 | 0 | 0 |
| Mar 26 | 0 | 0 | 0 | 0 |
| Apr 26 | 1 | 1 | 0 | 0 |
| May 26 | 0 | 1 | 0 | 0 |
| Jun 26 | 0 | 0 | 0 | 0 |
| Jul 26 | 0 | 0 | 0 | 0 |
| Aug 26 | 1 | 0 | 0 | 0 |
| Sep 26 | 0 | 3 | 0 | 0 |
| Oct 26 | 0 | 1 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Device types named most often
Last 12 months, by FDA product code. A company that sells more gets more reports.
3 more in this ranking with a free account
Brand names named most often
Last 12 months, as written on the reports. One product can appear under several spellings.
- EF15
3 more in this ranking with a free account
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- Medshape Universal Joints, REF: DNE-9000-UJOpen, Classified
Z-2513-2025 · Started Jun 2, 2025 · Posted by FDA Sep 3, 2025
Reason given: Bone external fixation system may have the pin that can become dislodged resulting in frame instability, the use of this product may cause a delay in surgery or a revision if the device is use.
Cause as FDA categorized it: Process control · Device type: Appliance, Fixation, Nail/Blade/Plate Combination, Multiple Component (KTT)
- DYNANAIL MINI, Endcap +6mm, REF 2600-05-006, Rx Only, SterileOpen, Classified
Z-0453-2022 · Started Nov 17, 2021
Reason given: The firm identified a nonconformance in Lot 04882 involving the endcap being manufactured to a longer length than indicated in product specifications, introducing the risk of the +6 mm endcap not seating flush with the nail while inserting during a procedure.
Cause as FDA categorized it: Device Design · Device type: Screw, Fixation, Bone (HWC)
Z-1276-2013 · Started Apr 4, 2013 · Posted by FDA May 8, 2013
Reason given: Expiration date on the patient label and date on the product carton were not the same.
Cause as FDA categorized it: Error in labeling · Device type: Fastener, Fixation, Nondegradable, Soft Tissue (MBI)
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.